Nov 09, 2021 7:00am EST XORTX Therapeutics Announces Partial Exercise of Over-Allotment Option Pursuant to US Public Offering
Nov 04, 2021 2:48pm EDT XORTX Therapeutics Clarifies Halt of Trading in Canada and Timing for Commencement of Trading on TSX Venture Exchange
Nov 02, 2021 6:13pm EDT XORTX Therapeutics Receives Final Approval to List on the TSX Venture Exchange
Oct 13, 2021 7:55am EDT XORTX Therapeutics Announces Pricing of US$12 Million Public Offering and Nasdaq Listing